We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $931M
1-Year Est. Return 41.63%
This Fund
S&P 500
This Quarter Est. Return
-4.94%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$3.07B
AUM Growth
-$107M
Cap. Flow
-$138M
Cap. Flow %
-4.51%
Top 10 Hldgs %
75.54%
Holding
110
New
22
Increased
17
Reduced
17
Closed
30

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.72%
2 Consumer Discretionary 35.8%
3 Healthcare 25.32%
4 Industrials 0.67%
5 Financials 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERE
51
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$6.25M 0.2%
524,021
MTOR
52
DELISTED
MERITOR, Inc.
MTOR
$5.9M 0.19%
+750,100
New +$5.8M
DG icon
53
Dollar General
DG
$27.5B
$5.65M 0.18%
100,000
MTG icon
54
MGIC Investment
MTG
$6.31B
$5.46M 0.18%
750,000
-50,000
-6% -$355K
MAS icon
55
CALL
Masco
MAS
$13.5B
$5.32M 0.17%
+284,500
New +$5.07M
IMGN
56
CALL
DELISTED
Immunogen Inc
IMGN
$5.11M 0.17%
300,000
GDX icon
57
CALL
VanEck Gold Miners ETF
GDX
$28.3B
$5M 0.16%
200,000
CIT
58
CALL
DELISTED
CIT Group Inc.
CIT
$4.88M 0.16%
100,000
AIG icon
59
American International
AIG
$39.4B
$4.86M 0.16%
100,000
-100,000
-50% -$4.75M
SPHS
60
DELISTED
Sophiris Bio, Inc.
SPHS
$4.68M 0.15%
+1,000,000
New +$4.61M
CPAC
61
Cementos Pacasmayo
CPAC
$1.07B
$4.44M 0.14%
303,687
-16,313
-5% -$254K
PHM icon
62
CALL
Pultegroup
PHM
$22.5B
$4.13M 0.13%
+250,000
New +$4.26M
BLUE
63
DELISTED
bluebird bio
BLUE
$4.04M 0.13%
+11,580
New +$4.3M
LAB icon
64
Standard BioTools
LAB
$271M
$3.7M 0.12%
168,706
-144,193
-46% -$2.83M
PGEM
65
DELISTED
Ply Gem Holdings, Inc.
PGEM
$3.55M 0.12%
254,226
+104,226
+69% +$1.8M
QCOM icon
66
Qualcomm
QCOM
$192B
$3.37M 0.11%
+50,000
New +$3.28M
LEG
67
CALL
DELISTED
Leggett & Platt
LEG
$3.02M 0.1%
+100,000
New +$3.07M
NG icon
68
CALL
NovaGold Resources
NG
$3.17B
$2.78M 0.09%
1,200,000
MS icon
69
Morgan Stanley
MS
$337B
$2.69M 0.09%
+100,000
New +$2.68M
IRWD icon
70
Ironwood Pharmaceuticals
IRWD
$674M
$2.57M 0.08%
258,954
NG icon
71
NovaGold Resources
NG
$3.17B
$2.32M 0.08%
1,000,000
SUNE
72
DELISTED
SUNEDISON, INC COM
SUNE
$1.99M 0.06%
+250,000
New +$2.07M
MTOR
73
CALL
DELISTED
MERITOR, Inc.
MTOR
$1.97M 0.06%
250,000
-750,000
-75% -$5.8M
AGIO icon
74
Agios Pharmaceuticals
AGIO
$2.01B
$1.96M 0.06%
+70,000
New +$1.93M
LEN icon
75
Lennar Class A
LEN
$19.2B
$1.77M 0.06%
+52,528
New +$1.7M

Similar funds

Artal Group's Q3 2013 Portfolio in Review

As of Q3 2013, Artal Group held 110 positions worth $3.07B, down 3.4% from $3.18B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Artal Group withdrew a net $138M in Q3 2013, closing 30 positions and reducing 17 holdings. Its most notable exit was ONYX PHARMACEUTICALS INC, an estimated $26M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Artal Group opened a new position in Anywhere Real Estate worth $8.6M.

  • Artal Group's largest Q3 2013 buy was Anywhere Real Estate: 200,000 shares worth $8.6M.
  • Artal Group added most to Ford in Q3 2013, an estimated $5.07M increase.
  • Artal Group's biggest Q3 2013 reduction was Acorda Therapeutics, cutting an estimated $14.5M.
  • Artal Group fully exited ONYX PHARMACEUTICALS INC in Q3 2013, selling an estimated $26M.
  • Artal Group's ten largest holdings make up 76% of its $3.07B portfolio in Q3 2013.
  • Artal Group opened 22 new positions and closed 30 in Q3 2013.
  • Artal Group's portfolio value fell 3.4% quarter-over-quarter to $3.07B.

Based on Artal Group's 13F filing for Q3 2013, filed 14 Nov 2013.